Although these scores demonstrated improved performance in detecting early HCC, AFP is still a major contributor to the scores, and without optimal AFP sensitivity, their efficacy in identifying early HCC remains suboptimal. This evidence concerns the gene AFP and hepatocellular carcinoma.